| Literature DB >> 19954537 |
Alexander K Rowe1, Gabriel F Ponce de León, Jules Mihigo, Ana Carolina F S Santelli, Nathan P Miller, Pedro Van-Dúnem.
Abstract
BACKGROUND: Angola's malaria case-management policy recommends treatment with artemether-lumefantrine (AL). In 2006, AL implementation began in Huambo Province, which involved training health workers (HWs), supervision, delivering AL to health facilities, and improving malaria testing with microscopy and rapid diagnostic tests (RDTs). Implementation was complicated by a policy that was sometimes ambiguous.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19954537 PMCID: PMC2795764 DOI: 10.1186/1475-2875-8-275
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Algorithm used to analyse the quality of malaria diagnosis and treatment, as it was applied in outpatient health facilities, Huambo Province, Angola. a Defined as either fever (history of fever or axillary temperature > 37.5°C), or at least 3 of the following: headache, joint pain, chills, sweating, anaemia (palmor pallor), cough (applies to children only), anorexia, fatigue, vomiting, or diarrhoea. b Error (health worker's decision did not follow policy documents and training materials). c Result not available on the day of the consultation, patient asked to return the next day (this only occurred for 2 patients). d This part of the algorithm was not explicitly included in policy documents or training materials; however, the decision could be logically inferred from policy documents or training materials. e Defined as cerebral dysfunction, cerebral malaria, disseminated intravascular coagulopathy, haemoglobinuria, hepatic dysfunction, hyperthermia, pulmonary oedema, renal insufficiency, severe anaemia, or shock. For details, see Figure 2. f Do not treat for malaria now; wait until result is ready and treat only if test is positive. g Defined as dysentery, hepatitis, influenza-like illness, measles, otitis, pneumonia, or urinary tract infection. For details, see Figure 2.
Figure 2Definitions used in the survey analysis.
Figure 3Dosage for artemether-lumefantrine used in the survey analysis.
Availability of equipment, staff, and medicines needed to manage malaria and other febrile illnesses in outpatient health facilities, Huambo Province, Angola
| Characteristic | Health facilities with the characteristic (N = 33) | |
|---|---|---|
| No. | % (95% CI) | |
| Thermometer | 28 | 84.8 (76.8-92.9) |
| Functional scale for weighing children | 32 | 97.0 (93.1-100) |
| Booklet or chart with AL treatment algorithms for children and adults | 16 | 48.5 (37.3-59.6) |
| Staff trained to perform microscopy | 19 | 57.6 (46.5-68.6) |
| Functional microscope, according to the laboratory technician | 19 | 57.6 (46.5-68.6) |
| Staff trained to perform RDTs | 29 | 87.9 (80.6-95.2) |
| At least 25 valid (not expired) RDTs in stock | 31 | 93.9 (88.6-99.3) |
| Malaria testing, by microscopy or RDTa | 33 | 100 (89.4-100) |
| Malaria testing, by both microscopy and RDTsb | 13 | 39.4 (28.5-50.3) |
| Mosquito bed nets for distribution to patientsc | 0 | 0 (0-10.9) |
| AL blister packs for patients 5-14 kg | 26 | 78.8 (69.7-87.9) |
| AL blister packs for patients 15-24 kg | 33 | 100 (89.4-100) |
| AL blister packs for patients 25-34 kg | 33 | 100 (89.4-100) |
| AL blister packs for patients ≥ 35 kg | 30 | 90.9 (84.5-97.3) |
| All four AL blister packs | 24 | 72.7 (62.8-82.7) |
| Amodiaquine tablets | 29 | 87.9 (80.6-95.2) |
| Quinine tablets | 12 | 36.4 (25.6-47.1) |
| Quinine or quinidine (injectable) | 18 | 54.4 (43.4-65.7) |
| Oral antibiotic (amoxicillin, ampicillin, cotrimoxazole, or erythromycin) | 31 | 93.9 (88.6-99.3) |
| Iron tablets | 27 | 81.8 (73.2-90.4) |
| AL blister packs for patients 5-14 kg | 7 | 21.2 (12.1-30.3) |
| AL blister packs for patients 15-24 kg | 12 | 36.4 (25.6-47.1) |
| AL blister packs for patients 25-34 kg | 12 | 36.4 (25.6-47.1) |
| AL blister packs for patients ≥ 35 kg | 10 | 30.3 (20.0-40.6) |
| All four AL blister packs | 4 | 12.1 (4.8-19.4) |
AL = artemether-lumefantrine; CI = confidence interval; RDT = rapid diagnostic test for malaria.
a Malaria testing was considered available if, on the day of the survey visit, the health facility had either: 1) a microscopist and a functional microscope, or 2) staff trained to perform RDTs and at least 25 valid (not expired) RDTs.
b On the day of the survey visit, the health facility had both of the following: 1) a microscopist and a functional microscope, and 2) a staff person trained to perform RDTs and at least 25 valid (not expired) RDTs.
c N = 32 health facilities, one value missing.
Health worker training and supervision in outpatient health facilities, Huambo Province, Angola
| Characteristic | Health workers with the characteristic (N = 93) | |
|---|---|---|
| No. | % (95% CI) | |
| Health worker received at least one formal training on AL use | 56 | 60.2 (47.7-72.8) |
| Health worker received informal training on AL use (i.e., a short, e.g., 1 hour, impromptu educational session provided by a supervisor or peer) | 60 | 64.5 (53.1-75.9) |
| Health worker received formal | 72 | 77.4 (66.6-88.2) |
| Health worker received at least 1 supervision visit in past 6 months | 68 | 73.1 (63.9-82.4) |
| Health worker received at least 1 supervision visit in past 6 months in | 32 | 34.4 (25.3-43.5) |
| Health worker supervised at least once in past 6 months on AL use | 47 | 50.5 (40.4-60.7) |
AL = artemether-lumefantrine; CI = confidence interval.
Patient characteristics in outpatient health facilities, Huambo Province, Angola
| Characteristic | No. and weighted percentage of patients | |
|---|---|---|
| n/N | % (95% CI) | |
| Among all patients | 136/177 | 77.8 (69.5-86.2) |
| Among patients < 5 years old | 62/72 | 79.5 (65.3-93.7) |
| Among patients ≥ 5 years old | 74/105 | 76.5 (66.1-86.9) |
| Patient (all ages) with suspected malaria had symptoms of a non-malaria cause of the febrile illness (e.g., a respiratory infection) | 63/136 | 48.0 (36.8-59.3) |
| Complicated malaria | 1/177 | 0.8 (0-2.4) |
| Uncomplicated malaria | 58/177 | 35.0 (26.0-44.1) |
| Not malaria | 118/177 | 64.2 (55.1-73.3) |
| Patient was tested for malaria with either microscopy or a rapid diagnostic test, whether or not indicated by the policy | 64/177 | 28.5 (17.9-39.2) |
| Patient with suspected malaria (i.e., test needed) was testedb | 58/136 | 30.7 (17.9-43.6) |
| Patient without suspected malaria (i.e., no test needed) was not tested | 35/41 | 79.2 (60.5-97.9) |
| Overall adherence to the testing policy (all ages)c | 93/177 | 41.5 (30.2-52.7) |
| Overall adherence to the testing policy (age < 5 years old)c | 36/72 | 40.0 (25.0-55.0) |
| Overall adherence to the testing policy (age ≥ 5 years old)c | 57/105 | 42.7 (27.7-57.6) |
CI = confidence interval.
a Defined as either fever (history of fever or axillary temperature > 37.5°C), or at least 3 of the following: headache, joint pain, chills, sweating, anaemia (palmor pallor), cough (applies to children only), anorexia, fatigue, vomiting, or diarrhoea.
b Microscopy and malaria rapid diagnostic tests were considered as equally appropriate tests.
c Patients needing testing got tested, and patients not needing testing did not get tested.
Predictorsa of correct malaria testing among patients with suspected malariab in outpatient health facilities, Huambo Province, Angola
| Attribute | No. of patients tested/no. of patients who needed testing (weighted %) | Multivariate | p-value |
|---|---|---|---|
| Health worker's caseload (all patients) on the day of the survey visit | |||
| 0-24 patients | 53/103 (49.0) | 18.4 (6.8-49.6) | < 0.0001 |
| 25-43 patients | 3/27 (7.5) | reference | |
| Patient's temperature measured by surveyor (N = 135; 1 missing value) | |||
| 39.0-39.9°C | 9/11 (80.5%) | odds ratio per 1°C | 0.0073 |
| 38.0-38.9°C | 3/9 (29.9%) | increase in measured | |
| 37.0-37.9°C | 19/37 (30.2%) | temperature: | |
| 36.0-36.9°C | 25/70 (26.2%) | 2.5 (1.3-5.0) | |
| 35.0-35.9°C | 1/8 (6.0%) | ||
| Health worker training on case-management policy recommending AL and diagnostic testing | |||
| Any training (formal or informal training) | 48/99 (38.1%) | 5.4 (0.9-33.5) | 0.072 |
| Not trained | 9/32 (17.2%) | reference |
AL = artemether-lumefantrine.
a This table presents results from the reduced model, which only included variables with multivariable p-values < 0.10. The full model, which included all variables with a univariate p-value < 0.15, also included health facility type (hospital versus health center), health worker supervised on AL use in the past 6 months, and health worker's age. In the full model, none of these factors had statistically significant associations with malaria testing (p-values ranged from 0.12 to 0.99). Both the full and reduced models were based on analyses of 129 patients because of missing values of predictors. The r-squared value for the full and reduced models were 94.9% and 94.4%, respectively.
b In this analysis, all the patients needed testing by either microscopy or a rapid diagnostic test.
Quality of malaria diagnosis in outpatient health facilities, Huambo Province, Angola
| Characteristic and patient sub-group | No. and weighted percentage of patients | |||
|---|---|---|---|---|
| n | % | (95% CI) | ||
| Uncomplicated malaria (major error) | 1 | 100 | (NC) | |
| Complicated malaria (minor error) | 2 | 2.6 | (0-6.4) | |
| Uncomplicated malaria (correct) | 32 | 60.1 | (44.5-75.7) | |
| No malariab (major error) | 24 | 37.4 | (21.6-53.1) | |
| Uncomplicated malaria (minor error) | 40 | 29.9 | (17.6-42.2) | |
| No malaria (correct) | 78 | 70.1 | (57.8-82.4) | |
| Correct (health worker diagnoses of malaria and no malaria matched gold standard diagnoses) | 110 | 66.1 | (58.3-73.8) | |
| Minor error (health worker incorrectly "over-diagnosed" uncomplicated malaria as complicated malaria, or over-diagnosed no malaria as uncomplicated malaria) | 42 | 20.1 | (11.4-28.7) | |
| Major error (health worker incorrectly "under-diagnosed" complicated malaria as uncomplicated malaria, or under-diagnosed uncomplicated malaria as no malaria) | 25 | 13.9 | (8.0-19.7) | |
CI = confidence interval; NC = not calculated.
a The "gold standard" malaria diagnosis (against which health worker diagnoses were compared) was defined by applying the analysis algorithm (Figure 1) to patient clinical signs and symptoms (assessed by surveyors, but information that should have been available to observed health workers) and laboratory data available to observed health workers (i.e., not the survey team's laboratory results).
b Health workers' diagnoses of the 24 patients were gastrointestinal illnesses (n = 10; e.g., gastritis, intestinal parasites, and dysentery), respiratory illnesses (n = 5; e.g., bronchitis), skin problems (n = 2; e.g., scabies and skin boils), and other (n = 7; e.g., dental caries, trauma, chicken pox, and malnutrition).
Quality of malariaa treatment in outpatient health facilities, Huambo Province, Angola
| Characteristic and patient sub-group | No. and weighted percentage of patients | |||
|---|---|---|---|---|
| n | % | (95% CI) | ||
| Correct (recommended treatment) | 105 | 61.4 | (52.0-70.7) | |
| Minor error | 42 | 22.3 | (12.3-32.3) | |
| Major error | 30 | 16.3 | (10.2-22.4) | |
| Correct (recommended treatment) | 27 | 49.0 | (33.5-64.5) | |
| Minor errorc | 2 | 5.4 | (0-13.2) | |
| Major errord | 30 | 45.6 | (28.2-63.1) | |
| Patient left the health facility with the recommended anti-malarial and knowledge of how to administer the drug at home | 17 | 27.1 | (14.8-39.4) | |
| Patient left the health facility with an adequate (but not recommended) anti-malarial and knowledge of how to administer the drug at home | 2 | 5.4 | (0-13.2) | |
| Patient left the health facility without at least one of the following: an effective anti-malarial or adequate knowledge of how to administer the drug at home | 40 | 67.5 | (53.6-81.5) | |
| Correct (recommended treatment) | 78 | 68.3 | (54.6-82.0) | |
| Minor error | 40 | 31.7 | (18.0-45.4) | |
AL = artemether-lumefantrine; CI = confidence interval.
a The "gold standard" malaria diagnosis (against which health worker treatments were compared) was defined by applying the analysis algorithm (Figure 1) to patient clinical signs and symptoms (assessed by surveyors, but information that should have been available to observed health workers) and laboratory data available to observed health workers (i.e., not the survey team's laboratory results).
b Quality in terms of anti-malarials prescribed by health workers. No error means that patients received recommended treatment in exact accordance with guidelines (malaria cases treated with the recommended anti-malarial with the recommended dosage, and non-malaria cases received no anti-malarial treatment). Minor error means that malaria cases received non-recommended, but still life-saving, anti-malarial treatment (either an overdose of a recommended anti-malarial, or an adequate dose of a non-recommended anti-malarial); and non-malaria cases received unnecessary anti-malarial treatment that was unlikely to cause serious harm. Major error means that malaria cases did not receive life-saving treatment (no anti-malarial, an ineffective anti-malarial, or an under-dosed anti-malarial).
c The 2 minor errors were: 1 case of uncomplicated malaria treated with correctly dosed quinine, and 1 case of uncomplicated malaria in a child < 5 kg treated with AL (with a dosage appropriate for a child 5-14 kg).
d The 30 major errors were: 26 cases of uncomplicated malaria not treated with anti-malarials, 2 cases of uncomplicated malaria treated with ineffective anti-malarials (1 treated with amodiaquine, 1 treated with sulfadoxine-pyrimethamine), 1 case of uncomplicated malaria treated with underdosed AL, and 1 case of complicated malaria treated with underdosed AL.
Use of AL: frequency of prescription, and appropriateness of dosing and counseling (whether or not AL was indicated, according to guidelines) in outpatient health facilities, Huambo Province, Angola
| Characteristic and patient sub-group | No. and weighted percentage of patients | |||
|---|---|---|---|---|
| n | % | (95% CI) | ||
| AL prescribed (whether or not indicated, according to guidelines) among all 177 patients | 62a | 35.5 | (24.9-46.2) | |
| Correctly dosed | 59 | 95.1 | (89.2-100) | |
| Underdosed | 2 | 3.9 | (51.4-88.4) | |
| Overdosed | 0 | 0 | (NC) | |
| AL not recommended (weight < 5 kg) | 1 | 1.0 | (0-3.1) | |
| First AL dose given during consultation (for the 62 patients who received AL) | 9 | 10.7 | (1.2-20.3) | |
| HW gave complete dosing instructions (definition of a dose, no. of doses/day, and treatment duration)b | 55 | 88.2 | (78.3-98.2) | |
| HW advised to take the medicine with food | 17 | 31.3 | (12.3-50.2) | |
| Patient could repeat all dosing instructions given by the HW (even if HW's dosage was incorrect)c | 43 | 60.9 | (44.2-77.6) | |
| HW advised to take the medicine with milk or fat-containing food | 4 | 4.9 | (0-10.8) | |
| HW advised to return for a follow-up visit | 8 | 14.4 | (0.4-28.3) | |
| HW advised to sleep under a bed net to prevent malaria | 0 | 0 | (NC) | |
| HW advised to return to the health facility if the patient becomes seriously ill | 5 | 5.8 | (0-11.8) | |
| HW advised to complete all the treatment (take all medicines) | 41 | 69.9 | (51.4-88.4) | |
AL = artemether-lumefantrine; CI = confidence interval; HW = health worker; NC = not calculated.
a Of these 62 patients, 59 actually had AL in hand; for the other 3 patients, AL had been prescribed but the medicines were not given.
b Dosing instructions were considered complete even if the dosage was incorrect, although in nearly all cases (53 of the 55 patients) the dosage was correct.
c Patient had to correctly repeat the definition of a dose, the number of doses per day, and the treatment duration. The response "ate que termine" (until all the medicines are done) was considered a correct response for treatment duration. The denominator of this statistic was 60 (2 missing values).
Figure 4Graphical pathway analysis of the case-management process for 40 patients without suspected malaria. AL = artemether-lumefantrine; HW = health worker.
Figure 5Graphical pathway analysis of the case-management process for 78 patients with suspected malaria but no gold standard malaria diagnosis. AL = artemether-lumefantrine; HW = health worker.
Figure 6Graphical pathway analysis of the case-management process for 59 patients with a gold standard malaria diagnosis. AL = artemether-lumefantrine; HW = health worker. a None of these 26 patients had been tested for malaria, although all were seen at health facilities in which testing was available.
Figure 7Causal diagram of the case-management process in outpatient health facilities, Huambo Province, Angola.